Mode of action: neurotoxicity induced by thyroid hormone disruption during development--hearing loss resulting from

Kevin M Crofton1, R Thomas Zoeller

  • 1US Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA. crofton.kevin@epa.gov

Insights

Polychlorinated biphenyls (PCBs) may cause hearing loss through a specific mode of action (MOA) in rats. However, human relevance is uncertain due to potential differences in toxicodynamics and exposure levels.

Area of Science:

  • Environmental Toxicology
  • Developmental Neurotoxicity
  • Risk Assessment

Background:

  • Mode of action (MOA) information is increasingly used in risk assessments to evaluate animal data relevance to humans.
  • The MOA/Human Relevance Framework (Meek et al., 2003) is utilized to assess animal MOAs for human applicability.
  • Polychlorinated biphenyls (PCBs) are environmental contaminants with potential developmental neurotoxic effects.

Purpose of the Study:

  • To examine the MOA of ototoxicity induced by PCBs in rats.
  • To evaluate the human relevance of the identified animal MOA using the MOA/Human Relevance Framework.
  • To identify data gaps and uncertainties in the interspecies extrapolation of the PCB ototoxicity MOA.

Main Methods:

  • Review of existing literature on PCB exposure, ototoxicity, and developmental neurotoxicity in animal models.
  • Application of the MOA/Human Relevance Framework to assess the confidence in the animal MOA and its relevance to humans.
  • Identification of key events in the MOA and evaluation of interspecies concordance.

Main Results:

  • High confidence in the postulated MOA of PCB-induced ototoxicity in rats.
  • Medium confidence in the interspecies concordance of key MOA events, with toxicodynamic differences moderating certainty.
  • Uncertainty regarding whether typical human exposures are sufficient to cause the hypothyroxinemia observed in rats, potentially impacting human fetal development and hearing.

Conclusions:

  • The MOA for PCB-induced ototoxicity in rats is well-established.
  • Confidence in human relevance is moderate due to potential interspecies differences in toxicodynamics and exposure levels.
  • Further research is needed on human fetal uridine diphosphoglucuronyltransferases (UGTs) inducibility and comparative sensitivity to xenobiotics to increase confidence in human risk assessment.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...